Targeting AKR1B1 inhibits metabolic reprogramming to reverse systemic therapy resistance in hepatocellular carcinoma

• Qi Wang
• Juan Liu
• Jiahong Dong

Article 01 August 2025

Featured

• 

  Neutrophil-specific targeting of STAT3 impairs tumor progression via the expansion of cytotoxic CD8⁺ T cells

  • Irem Ozel
  • Guanyu Sha
  • Jadwiga Jablonska

  ArticleOpen Access30 Aug 2025
• 

  Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial

  • Chuanhua Zhao
  • Yanqiao Zhang
  • Jianming Xu

  ArticleOpen Access06 Aug 2025
• 

  Epigenetic regulation of cancer stemness

  • Claudia Galassi
  • Gwenola Manic
  • Ilio Vitale

  Review ArticleOpen Access01 Aug 2025
• 

  Islet environment and development of type 1 diabetes in the biobreeding rat model

  • Patricia Recio-López
  • Per-Olof Berggren
  • Lisa Juntti-Berggren

  LetterOpen Access05 Aug 2025

Announcements

• 

  Behind the Paper

  In these Behind the Paper posts, our authors share the real stories behind the latest research papers, from conception to publication, the highs and the lows.

• 

  Cover Gallery

  Check out our journal covers and featured articles

• Published in partnership with West China Hospital, Sichuan University

  

Advertisement

Browse articles

• 

  Multiple sclerosis: molecular pathogenesis and therapeutic intervention

  • Imane Boutitah-Benyaich
  • Herena Eixarch
  • Carmen Espejo

  Review ArticleOpen Access02 Oct 2025
• 

  Sodium nitrate protects against metabolic syndrome by sialin-mediated macrophage rebalance

  • Shaorong Li
  • Yaning Wang
  • Songlin Wang

  ArticleOpen Access02 Oct 2025
• 

  Colony-stimulating factor 3 as a key mediator in the progression of idiopathic pulmonary fibrosis: a novel therapeutic target

  • Seungmo Kim
  • Yongjoong Kim
  • Su-Jae Lee

  ArticleOpen Access02 Oct 2025
• 

  Molecular signatures of skeletal muscle insulin resistance: bringing personalised diabetes treatment a step closer

  • Giovanni Levate
  • Roland H. Stimson

  Research HighlightOpen Access01 Oct 2025
• 

  Inhibition of long interspersed nuclear element-1 by nucleoside reverse transcriptase inhibitors attenuates vascular calcification

  • Jianshuai Ma
  • Dayu He
  • Hui Huang

  ArticleOpen Access01 Oct 2025
• 

  Development of a leucine-rich repeat-containing protein 15-targeted radio-immunotheranostic approach to deplete pro-tumorigenic mechanisms and immunotherapy resistance

  • Claire M. Storey
  • Mohamed Altai
  • David Ulmert

  ArticleOpen Access30 Sept 2025
• 

  A longevity-associated variant of the human BPIFB4 gene prevents diastolic dysfunction in progeria mice

  • Yan Qiu
  • Monica Cattaneo
  • Paolo Madeddu

  LetterOpen Access29 Sept 2025
• 

  Tumor microenvironment delineates differential responders to trastuzumab emtansine in HER2-positive metastatic breast cancer patients previously treated with pyrotinib: an exploratory biomarker analysis of a phase II study (NJMU-BC02)

  • Hong Pan
  • Ji Wang
  • Wenbin Zhou

  ArticleOpen Access29 Sept 2025
• 

  Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial

  • Bo Qiu
  • Yuanyuan Zhao
  • Hui Liu

  ArticleOpen Access29 Sept 2025

Trending - Altmetric

• 

  SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism

• 

  Inflammation and tumor progression: signaling pathways and targeted intervention

• 

  The mechanosensitive adhesion G protein-coupled receptor 133 (GPR133/ADGRD1) enhances bone formation

• 

  Arterial stiffness and vascular aging: mechanisms, prevention, and therapy

• 

  This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

•